✦ LIBER ✦

P2.153 Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease

✍ Scribed by W. Poewe; P. Barone; R. Hauser; Y. Mizuno; O. Rascol; A. Schapira; M. Haaksma; N. Juhel; L. Salin

Book ID: 117753707
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 62 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70504-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

P2.155 Simple overnight switching from i

P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage

✍ O. Rascol; P. Barone; R. Hauser; Y. Mizuno; W. Poewe; A. Schapira; C. Debieuvre; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB